Saeid Kargozar is a Fellow of the University of Texas Southwestern Medical Center (UTSW), USA. He was previously a Senior Assistant Professor of Tissue Engineering in the Department of Anatomy and Cell Biology, at Mashhad University of Medical Sciences in Iran. He received his M.S. in Medical Biotechnology in 2012 and his Ph.D. in Tissue Engineering in 2016, both from Tehran University of Medical Sciences, Iran. His current research interests include biocompatible materials and tissue engineering with special focus on bioactive glasses and the decellularized extracellular matrix (ECM). He is an active member of the American Ceramic Society and has published more than 118 peer-reviewed publications. According to a recent scientometric study published in PLOS Biology in 2021, he is listed amongst the top 2% of cited scientists in the world. Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• 1. Introduction to cancer2. Cancer therapy in the era of precision medicine3. Precision medicine: Aspects in translational medicine4. Biomaterials: Fundamentals, processing, and applications5. Possible targets for biomaterials in cancer treatment6. Biomaterials-based cancer diagnostics: Recent advances7. Anti-cancer biomaterials: A special design for precision medicine8. Natural plant-derived anti-cancer biomaterials9. Combination cancer therapy by bio-macromolecules and small molecules10. Biomaterials for cancer immunotherapy11. Biomaterials for engineering tumor microenvironment12. Biomaterials for cancer targeted drug delivery13. Engineered smart biomaterials for anti-cancer gene delivery‏14. Biofunctionalization of materials for targeting cancer cells15. Reactive oxygen species (ROS)‐responsive materials in cancer therapy16. Natural polymers for diagnosis and treatment of cancers17. Synthetic polymers for malignancies treatment18. Polymer-protein and polymer-drug conjugates in cancer therapy19. Magnetic calcium phosphates for imaging and treating of cancers20. Hydroxyapatite nanoparticles as anti-cancer agents21. Bioactive magnetic glass-ceramics for cancer treatment22. Mesoporous glasses in cancer therapy23. Carbon biomaterials for cancer therapy: opportunities and challenges24. Metals and metal compounds for cancer photothermal therapy25. Smart nanoparticles for the treatment of drug-resistant tumors26. Managing malignancies by magnetic electrospun nanofibers27. Multiparametric preclinical assessment of theranostics materials28. Health risk assessment of anti-cancer biomaterials29. Future perspectives and challenges for biomaterials

Saeid Kargozar is a Fellow of the University of Texas Southwestern Medical Center (UTSW), USA. He was previously a Senior Assistant Professor of Tissue Engineering in the Department of Anatomy and Cell Biology, at Mashhad University of Medical Sciences in Iran. He received his M.S. in Medical Biotechnology in 2012 and his Ph.D. in Tissue Engineering in 2016, both from Tehran University of Medical Sciences, Iran. His current research interests include biocompatible materials and tissue engineering with special focus on bioactive glasses and the decellularized extracellular matrix (ECM). He is an active member of the American Ceramic Society and has published more than 118 peer-reviewed publications. According to a recent scientometric study published in PLOS Biology in 2021, he is listed amongst the top 2% of cited scientists in the world. Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• 1. Introduction to cancer2. Cancer therapy in the era of precision medicine3. Precision medicine: Aspects in translational medicine4. Biomaterials: Fundamentals, processing, and applications5. Possible targets for biomaterials in cancer treatment6. Biomaterials-based cancer diagnostics: Recent advances7. Anti-cancer biomaterials: A special design for precision medicine8. Natural plant-derived anti-cancer biomaterials9. Combination cancer therapy by bio-macromolecules and small molecules10. Biomaterials for cancer immunotherapy11. Biomaterials for engineering tumor microenvironment12. Biomaterials for cancer targeted drug delivery13. Engineered smart biomaterials for anti-cancer gene delivery‏14. Biofunctionalization of materials for targeting cancer cells15. Reactive oxygen species (ROS)‐responsive materials in cancer therapy16. Natural polymers for diagnosis and treatment of cancers17. Synthetic polymers for malignancies treatment18. Polymer-protein and polymer-drug conjugates in cancer therapy19. Magnetic calcium phosphates for imaging and treating of cancers20. Hydroxyapatite nanoparticles as anti-cancer agents21. Bioactive magnetic glass-ceramics for cancer treatment22. Mesoporous glasses in cancer therapy23. Carbon biomaterials for cancer therapy: opportunities and challenges24. Metals and metal compounds for cancer photothermal therapy25. Smart nanoparticles for the treatment of drug-resistant tumors26. Managing malignancies by magnetic electrospun nanofibers27. Multiparametric preclinical assessment of theranostics materials28. Health risk assessment of anti-cancer biomaterials29. Future perspectives and challenges for biomaterials

Saeid Kargozar is a Fellow of the University of Texas Southwestern Medical Center (UTSW), USA. He was previously a Senior Assistant Professor of Tissue Engineering in the Department of Anatomy and Cell Biology, at Mashhad University of Medical Sciences in Iran. He received his M.S. in Medical Biotechnology in 2012 and his Ph.D. in Tissue Engineering in 2016, both from Tehran University of Medical Sciences, Iran. His current research interests include biocompatible materials and tissue engineering with special focus on bioactive glasses and the decellularized extracellular matrix (ECM). He is an active member of the American Ceramic Society and has published more than 118 peer-reviewed publications. According to a recent scientometric study published in PLOS Biology in 2021, he is listed amongst the top 2% of cited scientists in the world. Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• 1. Introduction to cancer2. Cancer therapy in the era of precision medicine3. Precision medicine: Aspects in translational medicine4. Biomaterials: Fundamentals, processing, and applications5. Possible targets for biomaterials in cancer treatment6. Biomaterials-based cancer diagnostics: Recent advances7. Anti-cancer biomaterials: A special design for precision medicine8. Natural plant-derived anti-cancer biomaterials9. Combination cancer therapy by bio-macromolecules and small molecules10. Biomaterials for cancer immunotherapy11. Biomaterials for engineering tumor microenvironment12. Biomaterials for cancer targeted drug delivery13. Engineered smart biomaterials for anti-cancer gene delivery‏14. Biofunctionalization of materials for targeting cancer cells15. Reactive oxygen species (ROS)‐responsive materials in cancer therapy16. Natural polymers for diagnosis and treatment of cancers17. Synthetic polymers for malignancies treatment18. Polymer-protein and polymer-drug conjugates in cancer therapy19. Magnetic calcium phosphates for imaging and treating of cancers20. Hydroxyapatite nanoparticles as anti-cancer agents21. Bioactive magnetic glass-ceramics for cancer treatment22. Mesoporous glasses in cancer therapy23. Carbon biomaterials for cancer therapy: opportunities and challenges24. Metals and metal compounds for cancer photothermal therapy25. Smart nanoparticles for the treatment of drug-resistant tumors26. Managing malignancies by magnetic electrospun nanofibers27. Multiparametric preclinical assessment of theranostics materials28. Health risk assessment of anti-cancer biomaterials29. Future perspectives and challenges for biomaterials